Skip to main content
Premal Thaker, MD, Obstetrics & Gynecology, Saint Louis, MO, Siteman Cancer Center

PremalHarishThakerMD

Obstetrics & Gynecology Saint Louis, MO

Gynecologic Oncology

Associate Professor, Obstetrics & Gynecology, Washington University School of Medicine

Overview of Dr. Thaker

I am an Associate Professor in the Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Washington University in St. Louis, Missouri as well as a Clinician and a Research Member at the Siteman Cancer Center of Washington University. I trained as a cancer biologist during my fellowship at MD Anderson Cancer Center with emphasis in cell and molecular biology including angiogenesis and invasion in ovarian cancer. Now I am interested in novel therapeutics in all gynecologic cancers and have led national as well as institutional clinical trials in ovarian, cervical, and endometrial malignancies. Currently, I run our Division’s clinical trial research efforts.

Education & Training

  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 2006
  • University of Texas
    University of TexasMS, Cancer Biology, 2004
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Obstetrics and Gynecology, 1999 - 2002
  • Drexel University College of Medicine/Hahnemann University Hospital
    Drexel University College of Medicine/Hahnemann University HospitalResidency, Obstetrics and Gynecology, 1997 - 1999
  • MCP-Hahnemann College of Medicine
    MCP-Hahnemann College of MedicineClass of 1997, MD
  • Villanova University
    Villanova UniversityBA, Biology, 1995

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 2006 - 2024
  • IL State Medical License
    IL State Medical License 2020 - 2023
  • TX State Medical License
    TX State Medical License 2003 - 2016
  • PA State Medical License
    PA State Medical License 1998 - 2012
  • American Board of Obstetrics and Gynecology Obstetrics & Gynecology
  • American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

  • Outstanding Publication Award for 2016 of an NRG Oncology Publication on cervical cancer in Annals of Oncology 2017
  • Certificate of Excellence in Reviewing Editors of Gynecologic Oncology and Gynecologic Oncology Case Reports, 2014
  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Modified Frailty Index Is Predictive of Wound Complications in Obese Patients Undergoing Gynecologic Surgery via a Midline Vertical Incision  
    Premal Thaker, MD, Gynecologic Oncology
  • Life Stress as a Risk Factor for Sustained Anxiety and Cortisol Dysregulation During the First Year of Survivorship in Ovarian Cancer  
    Anil K Sood, Premal H Thaker, Laila Dahmoush, Cancer
  • Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian Cancer  
    Ian S Hagemann, Premal H Thaker, Carolyn K McCourt, Katherine C Fuh, David G Mutch, Andrea R Hagemann, Matthew A Powell, Clinical Cancer Research
  • Join now to see all

Press Mentions

  • Novel Immunotherapeutic Agent Shows Benefit in Ovarian Cancer
    Novel Immunotherapeutic Agent Shows Benefit in Ovarian CancerAugust 10th, 2015
  • Celsion's GEN-1 Immunotherapy Highlighted in Oppenheimer's Expert Call on Ovarian Cancer Treatment Landscape and Emerging Opportunities
    Celsion's GEN-1 Immunotherapy Highlighted in Oppenheimer's Expert Call on Ovarian Cancer Treatment Landscape and Emerging OpportunitiesAugust 9th, 2019
  • Afternoons on 11: Spotlight on Ovarian Cancer
    Afternoons on 11: Spotlight on Ovarian CancerApril 4th, 2016
  • Join now to see all

Committees

  • Member, Ovarian Committee, NRG Oncolgoy Group 2011 - 2018
  • Member, Phase I Committee, NRG Oncology Group 2007 - 2018

Research History

  • Biobehavioral Influences on Ovarian Cancer Progression: Role of Chemoresistance2016 - 2020
  • Leading Academic Participating SitesThe goal of this project is to improve patient accrual to clinical trials at NCI designated cancer centers.2014 - 2019
  • Gynecologic Oncology Support fundThe goal of the project is to support research in ovarian cancer targeting the identification of clinically relevant targets in ovarian cancer.2017 - 2018
  • Molecular Oncology Training GrantI serve as a clinical mentor to Ph.D. students in order for them to better understand how to translate bench findings in clinical problems.2005 - 2018

Professional Memberships

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    Anthem Blue Access Choice PPO
    Anthem Blue Access PPO
    BCBS Blue Card PPO
    BCBS Illinois PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Coventry Health Care PPO Platinum
    Coventry Missouri - HMO/POS
    First Health PPO
    Great West PPO
    HealthLink PPO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment